Gilsbar to License Elsevier / MEDai’s Risk Navigator Clinical® to Identify and Manage High Risk Populations and Improve Patient Care Quality
Orlando, FL, January 17, 2012 – Elsevier/MEDai, the leader in predictive clinical analytic solutions, today announced Gilsbar, Inc. has licensed MEDai’s Risk Navigator Clinical to proactively use analytics to provide value to their clients by identifying programs that will provide a return on investment for their constituents. Further they will support Care Management through the identification and management of high-risk members.
“With Elsevier / MEDai’s Risk Navigator Clinical, our clients will be able to measure and monitor compliance to evidence-based guidelines and provide information to employers regarding population and group management,” said Douglas Layman, Executive Vice President & CSMO, Gilsbar. “As more and more payers focus on gaining efficiencies and improving quality, the predictive modeling enabled by Risk Navigator Clinical will help our clients turn their data into actionable information so they can achieve both.”
Gilsbar, based in Covington, LA., is one of the nation’s fastest growing, private health and benefit management organizations. Gilsbar’s three divisions – including Health & Benefit Management, MedCom Care Management and MedCom Care Advocates – provide proven methodologies to help keep members healthy and curb healthcare spend. Gilsbar’s clients include benefit advisors, employers, associations, affinity groups, and insurance carriers.
“As Gilsbar supports its clients utilizing Risk Navigator Clinical, it can look forward to having a greater ability to identify and manage high risk populations utilizing claims and biometric data and ultimately improve the health status of their clients’ employees and families,” said Tom Zajac, President, Elsevier / MEDai. “Risk Navigator Clinical is the only predictive tool that gives payers a true 360-degree view of their member populations.”
Gilsbar also plans to use Risk Navigator Clinical with its clients to conduct group reporting, provide feedback to employer groups and incorporate risk scores into actuarial models.
“Risk Navigator Clinical will help Gilsbar to proactively select at-risk individuals for interventions more effectively than before and will improve their support of wellness programs,” said Hank Miltenberger, President and CEO of Gilsbar. “These programs will provide a demonstrated return on investment for our clients and improve the overall health of their members.”
For more information about MEDai’s Risk Navigator Clinical, please go to www.medai.com.
# # #
About Elsevier / MEDai
Elsevier/MEDai, Inc. is a leading health information company offering award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payers and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time, and improve outcomes. For more information on Elsevier / MEDai, visit www.medai.com. Its parent company, Elsevier, is a world-leading provider of scientific, technical and medical information products and services, with more than 7,000 employees in over 70 offices across 24 countries.
Gilsbar® is one of the fastest growing, privately-held health and benefit management organizations in the country. Its divisions include TPA Services, MedCom Care Management, and Care Advocates. The Gilsbar group of companies is committed to improving the health and well-being of the clients they serve. They work with employers, benefit consultants, associations, carriers, and individuals nationwide. Gilsbar has been honored by Inc. magazine for its sustained growth and by Modern Healthcare and Business Insurance magazines as a Best Place to Work. For more information, visit www.gilsbar.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Vice President, Global Corporate Relations, Elsevier
+1 215 239 3508